Recon: Supreme Court takes up ‘skinny labeling’ case; EC proposal would double EU regulators medtech staffs

• Tylenol use during pregnancy not linked to autism, new study says (STAT)
• Supreme Court agrees to review ‘skinny labeling’ and generic drug access (STAT)
• Limit on multiyear funding of NIH grants is a sticking point in Senate budget talks (STAT)
• Some drugmakers quietly concerned about legal risk with speedy FDA review program (Reuters)
• Trump announces "The Great Healthcare Plan," but it's sparse on details (CBS News)

• Novo Nordisk Foundation gives $850M to nonprofit to help commercialize research in Europe (STAT)
• Makary cites higher FDA user fees as one key to counter China biotech (Endpoints)
• European regulators recommended 38 novel drugs in 2025, 15 fewer than the FDA (Endpoints)
• Europe Relies Too Much on China for Drugs, Fresenius CEO Warns (Bloomberg)
• Commission Proposal Expected To More Than Double EU Regulators’ Medtech Staff (MedTech Insight)
• EY Study Lays Bare Extent Of Regulatory Toll On Europe’s Medtech Sector (MedTech Insight)

• Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly (Reuters)
• Genmab and AbbVie's blood cancer drug fails to improve survival in late-stage study (Reuters)
• Agomab and SpyGlass file for IPOs as investor enthusiasm builds after JPM (Endpoints)
• Large drugmakers without a US pricing pact are bracing to make one (Endpoints)
• Generic GLP-1s are coming this year. The CEO in charge doesn't know what to expect (Endpoints)
• ImmunityBio's cell therapy posts encouraging early results in rare form of lymphoma (Endpoints)

• Intuitive says general surgery, acute care fuel US robot momentum (MedTech Dive)
• STAAR CEO exits after company rejects Alcon buyout (MedTech Dive)
• Siemens Healthineers Targets 5–6% Growth, Rules Out Large M&A As Tariff Mitigation Takes Shape (MedTech Insight)
• More Medtech Dialog And Supercharged Hospital And DRGs Reform In Packed 2026 German Agenda (MedTech Insight)
• Philips Exec: Innovation Launches Breakthrough Era For Imaging (MedTech Insight)

• Behind new dietary guidelines: Industry-funded studies, opaque science, crushing deadline pressure (STAT)
• Abandoning packaging sustainability is a ‘serious strategic miscalculation’: Bain (Food Dive)

• Former AMA president says the U.S. health care system will implode without an overhaul (STAT)
• US Supreme Court to hear Bayer's bid to curb Roundup cases (Reuters)
• The Push for Lower US Drug Prices Uses Bad Logic (Bloomberg)